RUBINSTEIN JULIE

CIK 00017806641 companySEATTLE, WA

SEC Profile

Transactions

Companies

Filings

CIK

0001780664

Recent Transactions

50 trades

Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2026-03-10$14.68/sh−19,460→ 643,471 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Common Stock
2026-03-10$6.55/sh+14,722→ 662,531 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Stock Option (right to buy)
2026-03-10−400→ 403,539 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Common Stock
2026-03-10$12.14/sh+400→ 662,931 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Stock Option (right to buy)
2026-03-10−14,722→ 106,993 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Common Stock
2026-03-09$12.14/sh+11,881→ 678,750 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2026-03-09$14.79/sh−30,941→ 647,809 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Common Stock
2026-03-09$6.55/sh+14,722→ 666,869 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Stock Option (right to buy)
2026-03-09−14,722→ 121,715 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Stock Option (right to buy)
2026-03-09−11,881→ 403,939 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Common Stock
2026-03-06$6.55/sh+14,722→ 671,207 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Stock Option (right to buy)
2026-03-06−14,722→ 136,437 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2026-03-06$15.14/sh−30,941→ 652,147 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Stock Option (right to buy)
2026-03-06−11,881→ 415,820 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Common Stock
2026-03-06$12.14/sh+11,881→ 683,088 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Stock Option (right to buy)
2026-03-05−14,722→ 151,159 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2026-03-05$16.00/sh−30,941→ 575,235 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Common Stock
2026-03-05$12.14/sh+11,881→ 606,176 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Stock Option (right to buy)
2026-03-05−11,881→ 427,701 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Common Stock
2026-03-05$6.55/sh+14,722→ 594,295 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Common Stock
2026-03-04$6.55/sh+14,722→ 598,633 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Common Stock
2026-03-04$12.14/sh+11,881→ 610,514 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Stock Option (right to buy)
2026-03-04−14,722→ 165,881 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Stock Option (right to buy)
2026-03-04−11,881→ 439,582 total
Award
Adaptive Biotechnologies Corp$ADPT
Common Stock
2026-03-04+81,250→ 656,485 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2026-03-04$16.60/sh−30,941→ 579,573 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2026-03-03$16.33/sh−6,518→ 583,911 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2026-03-03$15.49/sh−24,423→ 590,429 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Common Stock
2026-03-03$6.55/sh+14,722→ 602,971 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Stock Option (right to buy)
2026-03-03−11,881→ 451,463 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Common Stock
2026-03-03$12.14/sh+11,881→ 614,852 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Stock Option (right to buy)
2026-03-03−14,722→ 180,603 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2025-03-05$6.99/sh−19,461→ 588,249 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2025-03-05$6.98/sh−40,044→ 607,710 total
Award
Adaptive Biotechnologies Corp$ADPT
Common Stock
2025-03-04+175,000→ 647,754 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2024-03-05$3.43/sh−25,580→ 486,244 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2024-03-05$3.56/sh−13,490→ 472,754 total
Award
Adaptive Biotechnologies Corp$ADPT
Common Stock
2024-03-04+175,000→ 511,824 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2023-03-06$8.57/sh−22,668→ 336,824 total
Award
Adaptive Biotechnologies Corp$ADPT
Stock Option (right to buy)
2023-03-06+199,549→ 199,549 total
Award
Adaptive Biotechnologies Corp$ADPT
Common Stock
2023-03-06+132,979→ 359,492 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2022-03-07$12.01/sh−4,613→ 226,513 total
Award
Adaptive Biotechnologies Corp$ADPT
Common Stock
2022-03-04+185,338→ 231,126 total
Award
Adaptive Biotechnologies Corp$ADPT
Stock Option (Right to Buy)
2022-03-04+463,344→ 463,344 total
Award
Adaptive Biotechnologies Corp$ADPT
Stock Option (Right to Buy)
2021-03-04+114,469→ 114,469 total
Award
Adaptive Biotechnologies Corp$ADPT
Common Stock
2021-03-04+45,788→ 45,788 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Stock Option (Right to Buy)
2021-03-01−15,000→ 225,325 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2021-03-01$58.64/sh−9,471→ 845 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Common Stock
2021-03-01$6.55/sh+15,000→ 15,000 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2021-03-01$58.99/sh−845→ 0 total

Companies

Adaptive Biotechnologies Corp
President and COO
$ADPT

Recent Filings

Address

C/O ADAPTIVE BIOTECHNOLOGIES CORPORATION 1165 EASTLAKE AVENUE EAST

SEATTLE, WA, 98109

View on SEC.gov